InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Explore the detailed record of transactions filed by Dougan Brady W, Director. Director active across 1 companies, notably Humacyte, Inc.. Aggregated, 5 disclosures have been logged. Total volume traded: €457k. The latest transaction was filed on 23 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
€45,21610,000 shares@ €4.52169.9% of flow
Common Stock
SEC:0001818382-22-000051:0·
Ideal exit: 17 Feb 2023 (T+270)
€205,71123,694 shares@ €8.68245.0% of flow
Common Stock
SEC:0001104659-21-150679:0·
€205,71123,694 shares@ €8.682100.0% of flow
Common Stock
SEC:0001104659-21-150679·
1,148,240 shares
Common Stock
SEC:0001104659-21-110543·
1,148,240 shares
Common Stock
SEC:0001104659-21-110543:0·
5 of 5 declarations
About Dougan Brady W
Dougan Brady W is a Board Member at Humacyte, Inc. He brings valuable expertise in corporate governance and strategy. In his role, he participates in overseeing the company's activities and making strategic decisions. Brady strives to ensure that the company adheres to ethical and regulatory standards while pursuing its growth objectives.
